Curaleaf Holdings (CURLF) Other financing activities (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Other financing activities of $258000.0 for Q4 2024, down 88.95% year-over-year from $2.3 million in Q1 2024, and up 2445.45% quarter-over-quarter from -$11000.0 in Q3 2024.
Curaleaf Holdings (CURLF) Other financing activities (2019 - 2024) Analysis & Trends
Curaleaf Holdings' Other financing activities history runs 6 years deep, the most recent figure standing at $258000.0 for Q4 2024.
- In Q4 2024, Other financing activities fell 88.95% year-over-year to $258000.0; the TTM figure through Dec 2024 stood at $230000.0 (up 21.05% YoY), while the FY2025 annual figure was $256000.0, up 64.1% from the prior year.
- Other financing activities for Q4 2024 stood at $258000.0, up from -$11000.0 in the prior quarter.
- The five-year high for Other financing activities was $2.3 million in Q4 2023, with the low at -$2.4 million in Q3 2023.
- The 5-year median for Other financing activities is $410500.0 (2020), against an average of $398812.5.
- The sharpest annual moves came in 2021 and 2023: Other financing activities soared 558.23% in 2021, then slumped 262.4% in 2023.
- Curaleaf Holdings' Other financing activities stood at $1.8 million in 2020, then tumbled by 150.9% to -$904000.0 in 2021, then soared by 194.69% to $856000.0 in 2022, then jumped by 172.78% to $2.3 million in 2023, then sank by 88.95% to $258000.0 in 2024.
- Business Quant data shows CURLF's Other financing activities at $258000.0 in Q4 2024, -$11000.0 in Q3 2024, and $2.3 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Curaleaf Holdings | 2.50 Bn | 2.40 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 258,000.00 |
| Dec 31, 2024 | 258,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Dec 31, 2023 | 2.34 Mn |
| Dec 31, 2023 | 2.34 Mn |
| Sep 30, 2023 | -2.35 Mn |
| Sep 30, 2023 | -2.35 Mn |
| Dec 31, 2022 | 856,000.00 |
| Dec 31, 2022 | 856,000.00 |
| Sep 30, 2022 | -649,000.00 |
| Sep 30, 2022 | -649,000.00 |
| Jun 30, 2022 | -689,000.00 |
| Jun 30, 2022 | -689,000.00 |
| Mar 31, 2022 | 463,000.00 |
| Mar 31, 2022 | 463,000.00 |
| Dec 31, 2021 | -904,000.00 |
| Dec 31, 2021 | -904,000.00 |
| Sep 30, 2021 | 1.39 Mn |
| Sep 30, 2021 | 1.39 Mn |